Retraction

A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion

Citations (79)

79
Total Citations
0
Post-Retraction
79
Pre-Retraction
0
Same Day
Glial cell-derived neurotrophic factor (GDNF) promotes low-grade Hs683 glioma cell migration through JNK, ERK-1/2 and p38 MAPK signaling pathways
Hyun Beom Song, Aree Moon
Neuroscience Research Open Access
Published: Jul 2006
71 citations
6855 days before retraction
Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line
Shakuntala Kondraganti, Christopher S. Gondi, Meena Gujrati et al. (7 authors)
International Journal of Oncology Open Access
Published: Jul 2006
44 citations
6858 days before retraction
ADAMTS1 Interacts with, Cleaves, and Modifies the Extracellular Location of the Matrix Inhibitor Tissue Factor Pathway Inhibitor-2
Antoni X. Torres‐Collado, Walter Kisiel, M. Luisa Iruela‐Arispe et al. (4 authors)
Journal of Biological Chemistry Open Access
Published: Apr 2006
57 citations
6923 days before retraction
FoxM1B Is Overexpressed in Human Glioblastomas and Critically Regulates the Tumorigenicity of Glioma Cells
Mingguang Liu, Bingbing Dai, Shin-Hyuk Kang et al. (12 authors)
Cancer Research Open Access
Published: Apr 2006
315 citations
6949 days before retraction
Analysis of sequence variations in the promoter region of the human tissue factor pathway inhibitor 2 gene in apoplectic patients and blood donors
Sabine Siegling, Elmar Thyzel, Joerg Glahn et al. (5 authors)
Annals of Hematology
Published: Oct 2005
8 citations
7108 days before retraction
Crystal Structure of Kunitz Domain 1 (KD1) of Tissue Factor Pathway Inhibitor-2 in Complex with Trypsin
Amy E. Schmidt, Hitendra S. Chand, Dulio Cascio et al. (5 authors)
Journal of Biological Chemistry
Published: Jun 2005
37 citations
7251 days before retraction
Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells
Yiwei Li, Xin Hong, Maha Hussain et al. (6 authors)
Molecular Cancer Therapeutics Open Access
Published: Mar 2005
44 citations
7345 days before retraction
Recombinant adeno‐associated virus (rAAV) expressing TFPI‐2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line
Niranjan Yanamandra, Shakuntala Kondraganti, Christopher S. Gondi et al. (7 authors)
International Journal of Cancer Open Access
Published: Feb 2005
61 citations
7356 days before retraction
Sequential 5-Aza 2′-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells
Federico Steiner, Julie A. Hong, Maria R. Fischette et al. (12 authors)
Oncogene Open Access
Published: Feb 2005
51 citations
7367 days before retraction
Role of Tissue Factor Pathway Inhibitor-2 in Ovarian Tumor Migration and Invasion
Ren Zhong, Ruibin Huang, Shan-Jun Song
The Chinese-German Journal of Clinical Oncology
Published: Feb 2005
5 citations
7373 days before retraction
Structure, function and biology of tissue factor pathway inhibitor-2
Hitendra S. Chand, Donald C. Foster, Walter Kisiel
Thrombosis and Haemostasis
Published: Jan 2005
111 citations
7404 days before retraction
Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma
Norihiro Sato, Antony R. Parker, Noriyoshi Fukushima et al. (7 authors)
Oncogene Open Access
Published: Dec 2004
159 citations
7423 days before retraction
Expression and characterization of the first kunitz domain of human tissue factor pathway inhibitor-2
Desheng Kong, Duan Ma, Hao Bai et al. (8 authors)
Biochemical and Biophysical Research Communications
Published: Oct 2004
32 citations
7473 days before retraction
Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis
Sajani S. Lakka, Christopher S. Gondi, Niranjan Yanamandra et al. (7 authors)
Oncogene
Published: May 2004
296 citations
7647 days before retraction
Integrative analysis of multiple gene expression profiles applied to liver cancer study
Jung Kyoon Choi, Jong Young Choi, Dae Ghon Kim et al. (10 authors)
FEBS Letters
Published: Apr 2004
97 citations
7671 days before retraction
Structure-Function Analysis of the Reactive Site in the First Kunitz-type Domain of Human Tissue Factor Pathway Inhibitor-2
Hitendra S. Chand, Amy E. Schmidt, S Paul Bajaj et al. (4 authors)
Journal of Biological Chemistry Open Access
Published: Apr 2004
62 citations
7679 days before retraction
Thrombin Up-regulates Tissue Factor Pathway Inhibitor-2 Synthesis through a Cyclooxygenase-2-dependent, Epidermal Growth Factor Receptor-independent Mechanism
Véronique Neaud, Jennifer Gillibert Duplantier, Claire Mazzocco et al. (5 authors)
Journal of Biological Chemistry Open Access
Published: Feb 2004
42 citations
7739 days before retraction
Tissue factor pathway inhibitor-2 (TFPI-2) recognizes the complement and kininogen binding protein gC1qR/p33 (gC1qR): implications for vascular inflammation
Ramona J. Petrovan, Berhane Ghebrehiwet, Wolfram Ruf et al. (4 authors)
Thrombosis and Haemostasis
Published: Jan 2004
25 citations
7770 days before retraction
Genetic variations in the human TFPI-2 gene and its promoter region by denaturing high performance liquid chromatography
Sabine Siegling, Elmar Thyzel, Thomas Brinkmann et al. (7 authors)
Thrombosis Research
Published: Jan 2004
4 citations
7770 days before retraction
Purification, Molecular Cloning, and Expression of a Novel Growth-Promoting Factor for Retinal Pigment Epithelial Cells, REF-1/TFPI-2
Yasuhiko Tanaka, Jun Utsumi, Mizuo Matsui et al. (13 authors)
Investigative Ophthalmology & Visual Science
Published: Dec 2003
16 citations
7780 days before retraction
The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice
Hitendra S. Chand, Xin Du, Duan Ma et al. (8 authors)
Blood
Published: Oct 2003
66 citations
7856 days before retraction
Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), in human glioma cells
Santhi D. Konduri, Kalkunte S. Srivenugopal, Niranjan Yanamandra et al. (12 authors)
Oncogene
Published: Jul 2003
78 citations
7938 days before retraction
The coagulation system as a target for experimental therapy of human gliomas
JT Loynes, L. R. Zacharski
Expert Opinion on Therapeutic Targets
Published: Jun 2003
8 citations
7984 days before retraction
Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line
Florent Hubé, Pascale Reverdiau, Sophie Iochmann et al. (5 authors)
Thrombosis Research Open Access
Published: Feb 2003
31 citations
8104 days before retraction
The ERK/MAPK Pathway Regulates the Activity of the Human Tissue Factor Pathway Inhibitor-2 Promoter
Christina Kast, Minglun Wang, Malcolm Whiteway
Journal of Biological Chemistry Open Access
Published: Feb 2003
42 citations
8104 days before retraction
Transcriptional Silencing of the TFPI-2 Gene by Promoter Hypermethylation in Choriocarcinoma Cells
Florent Hubé, Pascale Reverdiau, Sophie Iochmann et al. (6 authors)
Biological Chemistry Open Access
Published: Jan 2003
32 citations
8121 days before retraction
Computer model of the interaction of human TFPI-2 Kunitz-type serine protease inhibitor with human plasmin
Florent Hubé, Pascale Reverdiau, Sophie Iochmann et al. (4 authors)
Thrombosis Research Open Access
Published: Jan 2003
5 citations
8135 days before retraction
Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells
Santhi D. Konduri, Niranjan Yanamandra, Khawar Siddique et al. (11 authors)
Oncogene
Published: Dec 2002
73 citations
8155 days before retraction
Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas
Santhi D. Konduri, Francis Ali Osman, C.N. Rao et al. (13 authors)
Oncogene
Published: Jan 2002
13 citations
8470 days before retraction